Fluvoxamine Monotherapy for Psychotic Depression: The Potential Role of Sigma-1 Receptors

Annals of General Psychiatry - United Kingdom
doi 10.1186/1744-859x-8-26
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Sigma Receptors as Potential Therapeutic Targets for Neuroprotection

European Journal of Pharmacology
Pharmacology
2014English

Psychotic Depression

British Medical Journal
Medicine
2012English

The Cholinergic System, Sigma-1 Receptors and Cognition

Behavioural Brain Research
Behavioral Neuroscience
2011English

Pharmacological Treatment for Psychotic Depression

2013English

Chest Pain Following the Use of Fluvoxamine in Depression

Proceedings of Singapore Healthcare
Medicine
2018English

Development of Radiolabeled Probes Directed Against Sigma-1 Receptors

Bunseki Kagaku
Analytical Chemistry
2017English

Cocaine Inhibits Store-Operated Ca2+ Entry in Brain Microvascular Endothelial Cells: Critical Role for Sigma-1 Receptors

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2015English

Allosteric Modulation of Sigma-1 Receptors Elicits Rapid Antidepressant Activity

CNS Neuroscience and Therapeutics
PsychiatryMental HealthPhysiologyPharmacology
2016English

Hazards of Using Masking Protocols When Performing Ligand Binding Assays: Lessons From the Sigma-1 and Sigma-2 Receptors

Frontiers in Pharmacology
Pharmacology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy